Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL

Clinical trial NCT07677878 · RECRUITING

Trial details

NCT number: NCT07677878
Sponsor: Liping Dou
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

ALL (Acute B-Lymphoblastic Leukemia)

Start date: 2024-12-01
Primary completion: 2028-11-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.